Cargando…
A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic Resistance
Therapeutic resistance remains the most challenging aspect of treating cancer. Raf kinase inhibitory protein (RKIP) emerged as a molecule capable of sensitizing cancerous cells to radio- and chemotherapy. Moreover, this small evolutionary conserved molecule, endows significant resistance to cancer t...
Autores principales: | Al-Mulla, Fahd, Bitar, Milad S., Feng, Jingwei, Park, Sungdae, Yeung, Kam C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261143/ https://www.ncbi.nlm.nih.gov/pubmed/22279539 http://dx.doi.org/10.1371/journal.pone.0029532 |
Ejemplares similares
-
ROS constitute a convergence nexus in the development of IGF1 resistance and impaired wound healing in a rat model of type 2 diabetes
por: Bitar, Milad S., et al.
Publicado: (2012) -
Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer
por: Yousuf, Saad, et al.
Publicado: (2014) -
Upregulation of CREM/ICER suppresses wound endothelial CRE-HIF-1α-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes
por: Bitar, Milad S., et al.
Publicado: (2015) -
Targeting Raf Kinase Inhibitory Protein Regulation and Function
por: Yesilkanal, Ali Ekrem, et al.
Publicado: (2018) -
Raf kinase inhibitory protein reduces bradykinin receptor desensitization
por: Chivers, Samuel B., et al.
Publicado: (2022)